N/A N=4 Laparoscopic Sleeve Gastrectomy With Endoscopic Visualization
Morbid Obesity
Primary: Proportion of Procedures Completed With Successful Endoscopic Visualization. — 4 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=72 Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity
Morbid Obesity · Metabolic Syndrome X · Diabetes Mellitus
Primary: Excess Weight Loss From Baseline — 67.8; 64.2 percentage of EWL
N/A N=150 Gastric Procedures for Obesity
Morbid Obesity
Primary: Change in Body Weight — -21.4; -36.6; -7.0 kg
N/A N=30 Ileal Interposition With Sleeve Gastrectomy for Control of Diabetes
Diabetes
Primary: Percentage of Participants Having Remission of Type 2 Diabetes — 76.66 Percentage of Participants
N/A N=293 Clinical and Economic Outcomes in Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass Surgery
Morbid Obesity
Primary: Quality of Life (QOL) in First Postoperative Year According to EuroQol-5 Dimensions-5 Levels (EQ-5D-5L) — 3; 3 Score*months
N/A N=208 Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial)
Obesity · Hypertension · Diabetes Mellitus, Type 2
Primary: Percentage of Excess Weight Loss (EWL) — 3.2; 49.2; 44.1 percentage of EWL
N/A N=30 LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy
GERD · Gastroesophageal Reflux Disease
Primary: Percentage of Participants Reporting Greater Than or Equal to (>=) 50 Percent (%) Reduction in Total Gastroesophageal Reflux Disease (GERD)- Health-Related Quality of…
Phase 3 N=46 Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
Obesity
Primary: Weight — 127; 130; 126; 75 kilograms
N/A N=60 Endostapler Sleeve Gastrectomy Study
Obesity
Primary: Intraoperative Endoscopic Staple Line Bleeding Score — 1.63; 2.00 score on a scale
N/A N=106 Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy
Gastrectomy · Obesity
Primary: Number of Staple Load Firings — 5.26; 5.42 Number of staples
Phase 2 N=56 Multi-Center Pre-Bariatric Weight Loss Study
Obesity
Primary: Percent Excess Weight Loss (%EWL) at Week 12 — 11.9; 2.7 Percentage of Excess Weight Loss
N/A N=39 Sonographic Evaluation of Visceral Fat After Bariatric Surgery
Morbid Obesity
Primary: Decrease in the Visceral Fat Layer Measured by Ultrasound a Day Before and a Year After Surgery. — 3.6; 7.1; 5.6 visceral fat reduction in centimeters
N/A N=24 Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
Morbid Obesity · Weight Loss
Primary: Mean Weight Loss — 13.3 Pounds
Phase 2 N=22 Study for Pre-Surgical Weight Loss in Type II Diabetes Patients
Type 2 Diabetes · Obesity
Primary: % of Excess Weight Loss (EWL) — 37.7 % excess weight loss
N/A N=20 Endoscopic Suturing for Primary Obesity Treatment
Obesity · Body Weight · Overweight
Primary: Number of Participants With Adverse Events — 5; 2; 0; 13 Participants
N/A N=100 Anaesthesia for Laparoscopic Sleeve Gastrectomy
Obese
Primary: Analgesic Requirements. — 3.56; 1.67 mg
N/A N=15 Assessment of Gastric Volume Reduction in Surgical Weight Loss Candidates
Obesity
Primary: Successful Gastric Plication Using Reduction Gastroplasty — 9; 6 participants
Phase 4 N=83 Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
Post-operative Nausea and Vomiting · Laparoscopic Sleeve Gastrectomy
Primary: Number of Participants With PONV-related Delay of Hospital Discharge — 0; 4 Participants
N/A N=137 LAGB as a Treatment for Morbid Obesity in Adolescents
Morbid Obesity · Obstructive Sleep Apnea Syndrome · Metabolic Syndrome
Primary: Percentage of Excess Weight Change (EWL) — -35.5 percent change
N/A N=355 Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)
Morbid Obesity
Primary: Number of Participants With Postoperative Gastrointestinal Hemorrhage — 13; 39 participants
N/A N=197 Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
Morbid Obesity
Primary: Excess Weight Loss From Pre-operation to 5 Years Post-operation — 68.4; 45.4 percent change
N/A N=35 Gastric Tissue Stapler Comparison Study
Gastric Resection
Primary: Pressure Evaluation — 126; 163 mmHg
Phase 2 N=34 Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
Obesity · Status Post Sleeve Gastrectomy
Primary: Cohen's d (the Standardized Mean Difference) — 2.145 cohen's d
N/A N=24 Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Trial
Obesity
Primary: Durability — 1.2; 3.0; 1.4; 3.0 Score on a scale — p=<0.01
N/A N=15 Safety and Efficacy of Long Limb Roux-en Y Reconstruction
Diabetes Mellitus Type 2 in Nonobese · Gastric Cancer
Primary: Morbidity — 4 participants
Phase 4 N=43 Unilateral TAP Block for Laparoscopic Gastric Sleeve Surgery
Laparoscopic Sleeve Gastrectomy · Subcostal Transversus Abdominis Plane Block
Primary: Amount of 24 Hour Opioid Consumption — 44.7; 38.7 morphine milligram equivalents
N/A N=62 Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Hypoglycemia · Obesity
Primary: Mean Serum Glucose Levels — 123.1; 157.5; 103.2; 138 mg/dl
N/A N=57 Laparoscopic Adjustable Gastric Banding in Adolescents
Morbid Obesity
Primary: Total Weight Loss — 11.35 kilograms
N/A N=60 Endostapler Hemostasis Study
Intraoperative Staple Line Bleeding as Measured by the Provided Bleeding Severity Scale
Primary: Staple Line Bleeding — 2.08; 2.57 score on a scale — p=0.01
N/A N=9 Endoscopic Suturing System for Tissue Apposition
Obesity
Primary: Knotting Elements Placed — 11 elements